Medical device company Sanuwave has published preclinical data demonstrating the ability of the company's extracorporeal shock wave technology to stimulate proliferation of periosteal progenitor/adult stem cells within the body, according to a Sanuwave news release.
The technology reportedly significantly increases the quantity and quality of adult stem cells that can be harvested from the cambium layer for select tissue engineering and regenerative medicine applications. The study shows how the ESWT technology is able to proliferate adult stem cells within the periosteum of femurs and tibias in the rodent model.
The energy used to stimulate the adult stem cells did not damage surrounding tissue and the elevation of certain bone proteins during treatment could mean that ESWT promotes rapid vascularization of bone.
Related Articles on Orthopedic Devices:
Zimmer's New Hip Stem Available in US
LDR Moves Headquarters to Bigger Texas Facility
Symmetry Medical Acquires Surgical Implants Business for $165M
The energy used to stimulate the adult stem cells did not damage surrounding tissue and the elevation of certain bone proteins during treatment could mean that ESWT promotes rapid vascularization of bone.
Related Articles on Orthopedic Devices:
Zimmer's New Hip Stem Available in US
LDR Moves Headquarters to Bigger Texas Facility
Symmetry Medical Acquires Surgical Implants Business for $165M